Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Frankie Algieri | None | None | None | None | 05/24/2023 |
| Ronald Alvarez MD,MBA | Agenus Papivax |
AstraZeneca Pharmaceuticals LP Myriad Genetic Laboratories, Inc. Vaccitech |
None | None | 05/09/2023 |
| Deborah Armstrong MD | AstraZeneca Pharmaceuticals LP Clovis Oncology Eisai Inc. Pfizer Inc. |
Elucida TEON therapeutics |
None | None | 04/02/2023 |
| Floor Backes MD | AstraZeneca Pharmaceuticals LP Clovis Oncology Eisai Inc. Flatiron Health, Inc. GlaxoSmithKline ImmunoGen, Inc. Incyte Corporation Merck & Co., Inc. Mersana Natera Novocure Regeneron Pharmactcls Seattle Genetics, Inc. SUTRO Biopharma, Inc. Tempus Zentalis |
Agenus AstraZeneca Pharmaceuticals LP Clovis Oncology Eisai Inc. GlaxoSmithKline ImmunoGen, Inc. Merck & Co., Inc. Myriad Genetic Laboratories, Inc. |
None | UpToDate | 04/25/2023 |
| Lisa Barroilhet MD | None | Kiyatec | None | None | 01/06/2023 |
| Kian Behbakht MD | None | Kiyatec | None | None | 10/26/2022 |
| Andrew Berchuck MD | None | None | None | None | 05/28/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Lee-May Chen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GlaxoSmithKline |
None | None | None | 02/05/2023 |
| Joshua Cohen MD,FACOG,FACS | None | Sharsheret - Nonprofit providing support for patients with breast and ovarian cancer | None | None | 05/03/2023 |
| Marie DeRosa RN | None | None | None | None | 02/10/2023 |
| Eric Eisenhauer MD | None | None | None | None | 10/25/2022 |
| David Gershenson MD | National Cancer Institute Novartis Pharmaceuticals Corporation |
Aadi Genentech, Inc. Onconova Therapeutics Springworks Verastem |
None | Bristol-Myers Squibb Company|Elsevier|Johnson & Johnson|Procter & Gamble|UpToDate | 05/23/2023 |
| Heidi Gray MD | None | None | None | None | 03/05/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Rachel Grisham MD | Context Genentech, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Springworks Verastem |
None | Corcept Myriad Genetic Laboratories, Inc. Novartis Pharmaceuticals Corporation OncLive Plexus Verastem |
None | 10/31/2022 |
| Ardeshir Hakam MD | None | None | None | None | 04/25/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Lisa Hang PhD | None | None | None | Abbott Laboratories (spouse)|Abbvie (spouse)|BD (spouse) | 02/02/2023 |
| Brianna Herron PharmD,BCPS,BCOP | None | None | None | None | 05/17/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Angela Jain MD | None | None | None | None | 03/30/2023 |
| Amer Karam MD | None | None | AstraZeneca Pharmaceuticals LP GlaxoSmithKline |
UpToDate | 04/29/2023 |
| Gottfried Konecny MD | Eli Lilly and Company Merck & Co., Inc. |
None | AstraZeneca Pharmaceuticals LP GlaxoSmithKline ImmunoGen, Inc. Merck & Co., Inc. |
None | 04/19/2023 |
| Charles Leath III MSPH,MD | AbbVie, Inc. Agenus AstraZeneca Pharmaceuticals LP Celsion Corcept Therapeutics GlaxoSmithKline ImmunoGen, Inc. Incyte Corporation Merck & Co., Inc. National Cancer Institute PAREXEL International Corporation Rubius Therapeutics |
GlaxoSmithKline Merck & Co., Inc. Myriad Genetic Laboratories, Inc. Natera Seattle Genetics, Inc. |
None | None | 04/02/2023 |
| Gary Leiserowitz MD | None | None | None | None | 01/24/2023 |
| Joyce Liu MD,MPH | 2X Oncology Aravive Arch Oncology AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Clovis Oncology CytoMX Therapeutics Genentech, Inc. GlaxoSmithKline Regeneron Pharmaceuticals, Inc. Vigeo Therapeutics Zentalis |
AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Eisai Inc. EpsilaBio Genentech, Inc. GlaxoSmithKline |
None | None | 10/05/2022 |
| Lainie Martin MD | Agenus Inc. AstraZeneca Pharmaceuticals LP ImmunoGen, Inc. SUTRO Biopharma, Inc. Xencor |
Elucida SUTRO Biopharma, Inc. |
None | None | 03/06/2023 |
| Daniela Matei MD | AbbVie, Inc. Astex Pharmaceuticals Eisai Inc. Ipsen Merck & Co., Inc. PinotBio Regeneron Pharmaceuticals, Inc. |
AstraZeneca Pharmaceuticals LP CVS Eisai Inc. Eli Lilly and Company GlaxoSmithKline Merck & Co., Inc. Seattle Genetics, Inc. |
None | None | 10/18/2022 |
| Michael McHale MD | Versatem : stage IB/II Trial | None | None | None | 01/17/2023 |
| David Miller MD,FACS,FACOG | ADVAXIS INC ADVENCHEN LABORATORIES LLC Aeterna Zentaris Agenus Inc. AKESOBIO AUSTRALIA PTY LTD Aprea AB EMD SERONO RESEARCH & DEVELOPMENT INST ImmunoGen, Inc. Karyopharm Therapeutics Leap Therapeutics MATEON THERAPEUTICS Merck & Co., Inc. Millennium Pharmaceuticals, Inc. nVISION MEDICAL CORPORATION Pfizer Inc. Regeneron Pharmaceuticals, Inc. Syros Pharmaceuticals TRACON Pharmaceuticals, Inc. US BIOTEST INC |
AbbVie, Inc. Agenus Inc. AstraZeneca Pharmaceuticals LP Asymmetric Therapeutics, LLC Boston Biomedical Curio Science LLC Eisai Europe Ltd Eisai Inc. EMD Serono GlaxoSmithKline ImmunoGen, Inc. Incyte Corporation Karyopharm Therapeutics Merck & Co., Inc. Myriad Genetic Laboratories, Inc. Novartis Pharmaceuticals Corporation Novocure Seattle Genetics, Inc. Tarveda Tarveda Therapeutics |
None | None | 10/31/2022 |
| Sanja Percac-Lima PhD,MD | None | None | None | None | 09/05/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Elena Ratner MD | None | None | OncLive Zai labs |
None | 10/30/2022 |
| Sharon Robertson MD,MPH | None | None | None | None | 05/18/2023 |
| Kerry Rodabaugh MD | Immunovaccine Technologies | None | None | None | 01/21/2023 |
| John Schorge MD | None | None | None | None | 02/06/2023 |
| Bettyanne Sunderland OCN,RN,BSN | None | None | None | None | 01/27/2023 |
| Premal Thaker MD | Aravive Celsion Genentech, Inc. GlaxoSmithKline Iovance pharmaceuticals Merck & Co., Inc. Mersana Novocure Seattle Genetics, Inc. Verastem |
Aadi Pharmaceuticals Caris Life Sciences Celsion Clovis Oncology GlaxoSmithKline ImmunoGen, Inc. Incyte Corporation Novartis Pharmaceuticals Corporation Novocure zentalis |
None | None | 12/02/2022 |
| Shitanshu Uppal MD,FACOG,MBBS | None | None | None | None | 01/02/2023 |
| Roberto Vargas MD | None | None | None | None | 01/11/2023 |
| Erin Vidic | None | None | None | None | 02/13/2023 |
| Andrea Wahner Hendrickson MD | Amgen Inc. Prolynx |
Oxcia | CE Concepts MJH Life Sciences |
None | 04/11/2023 |
| Theresa Werner MD | None | Mersana | None | None | 04/12/2023 |
| Emese Zsiros PhD,MD | None | None | Aptitude Health Celldex Therapeutics Teneobio |
None | 07/14/2022 |